Menu

• Ask a Health Expert about LIGHT CHAIN ANALYSIS ABNORMAL
• Post Your Side Effect related to LIGHT CHAIN ANALYSIS ABNORMAL
• LIGHT CHAIN ANALYSIS ABNORMAL and FDA Warnings
• LIGHT CHAIN ANALYSIS ABNORMAL in Patients Wiki
• Report LIGHT CHAIN ANALYSIS ABNORMAL in Drug Side Effect Survey

LIGHT CHAIN ANALYSIS ABNORMAL side effect

What is LIGHT CHAIN ANALYSIS ABNORMAL ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Forteo Side Effects Report #5598554-5
Consumer or non-health professional from FRANCE reported FORTEO problem on Jan 16, 2008. Female patient, 71 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: light chain analysis abnormal, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Forteo Side Effects Report #5609340-1
FORTEO problem was reported by a Consumer or non-health professional from FRANCE on Jan 22, 2008. Female patient, 71 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: light chain analysis abnormal, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5400075-7
Pharmacist from UNITED STATES reported REVLIMID problem on July 26, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: light chain analysis abnormal, nephropathy, pain, pancytopenia, renal failure acute, therapeutic response decreased, . REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, FENTANYL TRANSDERMAL SYSTEM, HYDROMORPHINE, LISINOPRIL, OMEPRAZOLE, TEMAZEPAM, ALLOPURINOL. Patient was hospitalized. Patient recovered.

Revlimid Side Effects Report #5400075-7
REVLIMID problem was reported by a Pharmacist from UNITED STATES on July 26, 2007. Female patient was diagnosed with multiple myeloma and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: light chain analysis abnormal, nephropathy, pain, pancytopenia, renal failure acute, therapeutic response decreased, . REVLIMID dosage: 25MG DAILY 21D/28D PO. During the same period patient was treated with DEXAMETHASONE, FENTANYL TRANSDERMAL SYSTEM, HYDROMORPHINE, LISINOPRIL, OMEPRAZOLE, TEMAZEPAM, ALLOPURINOL. Patient was hospitalized. Patient recovered.


Azathioprine Side Effects Report #5663528-2
Consumer or non-health professional from UNITED KINGDOM reported AZATHIOPRINE problem on Feb 26, 2008. Male patient, 35 years of age, was diagnosed with renal transplant and was treated with AZATHIOPRINE. After drug was administered, patient experienced the following problems/side effects: epstein-barr virus infection, light chain analysis abnormal, lymphoproliferative disorder, skin lesion, skin nodule, . AZATHIOPRINE dosage: 100 MG; DAILY, 100 MG; DAILY. During the same period patient was treated with CYCLOSPORINE, PREDNISOLONE. Patient recovered.